|

Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis

RECRUITINGSponsored by National Medical Research Center for Therapy and Preventive Medicine
Actively Recruiting
SponsorNational Medical Research Center for Therapy and Preventive Medicine
Started2026-01-01
Est. completion2026-12-31
Eligibility
Age50 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07375433

Summary

Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.

Eligibility

Age: 50 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Verified diagnosis of COPD;
2. Patients hospitalized with COPD;
3. Citizenship of the Russian Federation;
4. Patients aged 50 to 70 years;
5. Patient consent to participate in the study.

Exclusion Criteria:

1. Lack of Russian Federaion citizenship;
2. Patient's refusal to participate in the study;
3. Any chronic diseases, other than COPD, that affect the prognosis, in the acute and/or decompensated stage;
4. Mental disorders.

Conditions4

COPDCOPD - Chronic Obstructive Pulmonary DiseaseHeart DiseaseHeart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)

Browse More Trials

Heart Disease trialsCOPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.